Literature DB >> 26386868

Caprini venous thromboembolism risk assessment permits selection for postdischarge prophylactic anticoagulation in patients with resectable lung cancer.

Krista J Hachey1, Philip D Hewes2, Liam P Porter2, Douglas G Ridyard2, Pamela Rosenkranz1, David McAneny1, Hiran C Fernando3, Virginia R Litle4.   

Abstract

OBJECTIVE: Postoperative venous thromboembolism (VTE) creates an 8-fold increase in mortality after lung resection. About one third of postoperative VTEs occur after discharge. The Caprini risk assessment model has been used by other specialties to calculate the risk of a VTE. Patients deemed high risk by the model are candidates for prophylactic anticoagulation after discharge, reducing the VTE risk by 60%. Our primary aims were to determine the frequency of VTE events and evaluate whether the Caprini model could risk-stratify patients.
METHODS: Patients undergoing lung cancer resections during 2005 to 2013 were evaluated. Exclusion criteria were preoperative filter and therapeutic anticoagulation. A total of 232 patients were reviewed and Caprini scores calculated. Subjects were risk stratified into groups of low risk (0-4), moderate risk (5-8), and high risk (≥ 9). Occurrence of VTE events (deep vein thrombosis; pulmonary embolism) were identified by imaging.
RESULTS: The 60-day VTE incidence was 5.2% (12 of 232); 33.3% occurred postdischarge (n = 4). Half (6 of 12) were pulmonary emboli, 1 of which caused a death, in an inpatient with a score of 16. The VTE incidence increased with Caprini score. Scores in the low, moderate, and high risk groups were associated with a VTE incidence of 0%, 1.7%, and 10.3%, respectively. With a high risk score cutoff of 9, the sensitivity, specificity, and accuracy are 83.3%, 60.5%, and 61.6%, respectively.
CONCLUSIONS: One third of VTE events occurred after discharge. Postoperative VTE incidence was correlated with increasing Caprini scores. Patients in the high risk group had an incidence of 10.3%. Elevated scores may warrant extended chemoprophylaxis for patients after discharge.
Copyright © 2016 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  embolism (venous); lung cancer; postoperative care

Mesh:

Substances:

Year:  2015        PMID: 26386868     DOI: 10.1016/j.jtcvs.2015.08.039

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  26 in total

1.  Venous thromboembolism events after thoracic surgery: global steps toward prevention.

Authors:  Robert M Van Haren; Virginia R Litle
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  Towards a precision medicine in venous thromboembolism associated to lung cancer.

Authors:  Luis Jara-Palomares; Teresa Elias-Hernandez; Maria Isabel Asensio-Cruz; Samira Marin-Romero; Remedios Otero-Candelera
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 3.  The Society for Translational Medicine: the assessment and prevention of venous thromboembolism after lung cancer surgery.

Authors:  Hui Li; Gening Jiang; Servet Bölükbas; Chun Chen; Haiquan Chen; Keneng Chen; Jun Chen; Xiangli Cui; Wentao Fang; Shugeng Gao; Sebastien Gilbert; Jianhua Fu; Xiangning Fu; Yasuhiro Hida; Shanqing Li; Xiaofei Li; Yin Li; Hecheng Li; Yongjun Li; Deruo Liu; Lunxu Liu; Jianxing He; Jie He; Giuseppe Marulli; Hiroyuki Oizumi; Marc de Perrot; René Horsleben Petersen; Yaron Shargall; Alan Sihoe; Qunyou Tan; Qun Wang; Shun Xu; Mei Yang; Yuanhua Yang; Zhentao Yu; Lanjun Zhang; Xun Zhang; Heng Zhao; Xiuyi Zhi
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

4.  Hypercoagulability After Resection of Thoracic Malignancy: A Prospective Evaluation.

Authors:  Michelle B Mulder; Kenneth G Proctor; Evan J Valle; Alan S Livingstone; Dao M Nguyen; Robert M Van Haren
Journal:  World J Surg       Date:  2019-12       Impact factor: 3.352

5.  Practice patterns in venous thromboembolism (VTE) prophylaxis in thoracic surgery: a comprehensive Canadian Delphi survey.

Authors:  John Agzarian; Lori-Ann Linkins; Laura Schneider; Waël C Hanna; Christian J Finley; Colin Schieman; Marc De Perrot; Mark Crowther; James Douketis; Yaron Shargall
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

6.  Establishment of Prediction Models for Venous Thromboembolism in Non-Oncological Urological Inpatients - A Single-Center Experience.

Authors:  Kaixuan Li; Meihong Yu; Haozhen Li; Quan Zhu; Ziqiang Wu; Zhao Wang; Zhengyan Tang
Journal:  Int J Gen Med       Date:  2022-03-24

7.  External Validation of a Venous Thromboembolic Risk Score for Cancer Outpatients with Solid Tumors: The COMPASS-CAT Venous Thromboembolism Risk Assessment Model.

Authors:  Alex C Spyropoulos; Joanna B Eldredge; Lalitha N Anand; Meng Zhang; Michael Qiu; Soheila Nourabadi; David J Rosenberg
Journal:  Oncologist       Date:  2020-02-04

Review 8.  European perspectives in Thoracic Surgery, the ESTS venous thromboembolism (VTE) working group.

Authors:  Yaron Shargall; Virginia R Litle
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

9.  A novel risk assessment model for venous thromboembolism after major thoracic surgery: a Chinese single-center study.

Authors:  Bo Tian; Hui Li; Songping Cui; Chunfeng Song; Tong Li; Bin Hu
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

10.  Postoperative venous thromboembolism after surgery for stage IA non-small-cell lung cancer: A single-center, prospective cohort study.

Authors:  Honghong Dong; Xiaoning Liang; Yingdi Gao; Yongsheng Cai; Xinyang Li; Jinbai Miao; Wenjiao Wang; Bin Hu; Hui Li
Journal:  Thorac Cancer       Date:  2022-03-22       Impact factor: 3.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.